Tanvir Choudhri, MD
Neurosurgery · New York, NYNPI 1043286727
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,269 of the $4,242 with a category attached, or 77.1%. Medtronic accounts for 86.4% of it on its own, with 5 other manufacturers making up the rest.
Across 41 payments — averaging $103.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Stryker$254
- DJO, LLC$163
- 4web, Inc.$123
- Orthofix Medical, Inc.$19
- Globus Medical$18
Across 1 payment — averaging $840.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$840
What the payments were for
- Travel & lodging$3,26977%
- Food & beverage$97323%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 28 | $3,665 |
| Stryker | 4 | $254 |
| DJO, LLC | 6 | $163 |
| 4web, Inc. | 1 | $123 |
| Orthofix Medical, Inc. | 1 | $19 |
| Globus Medical | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAZOR X SYSTEM$1,505
- CD HORIZON SPINAL SYSTEM$1,353
- MazorX - Renaissance$152
- SPINE TRUSS SYSTEM$123
How this compares
Too few neurosurgery providers in New Yorkto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 11 | $99 |
| Gabapentin | 12 | $81 |
Paid to pharmacies, not to this prescriber.
Other neurosurgery in New York
- Joshua BedersonNew York$12K
- Ning LinNew York$4K
- Isabelle GermanoNew York$4K
- Ori BarzilaiNew York$3K
- Caitlin HoffmanNew York$510
- Roee BerNew York$0
- David AltschulBronx$440K
- Alexandra PaulAlbany$90K
- Benjamin CohenRockville Centre$19K
- William SonsteinRockville Centre$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.